Compare ACHV & WHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACHV | WHG |
|---|---|---|
| Founded | N/A | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.6M | 157.9M |
| IPO Year | N/A | 2002 |
| Metric | ACHV | WHG |
|---|---|---|
| Price | $4.88 | $16.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | ★ 686.8K | 8.9K |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 3.55% |
| EPS Growth | N/A | ★ 154.57 |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | ★ $96,243,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $20.53 |
| Revenue Growth | N/A | ★ 4.20 |
| 52 Week Low | $1.84 | $13.49 |
| 52 Week High | $5.78 | $18.97 |
| Indicator | ACHV | WHG |
|---|---|---|
| Relative Strength Index (RSI) | 60.25 | 56.71 |
| Support Level | $3.82 | $15.31 |
| Resistance Level | $4.99 | $16.93 |
| Average True Range (ATR) | 0.32 | 0.63 |
| MACD | -0.01 | 0.10 |
| Stochastic Oscillator | 90.17 | 90.56 |
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.